332
Participants
Start Date
March 31, 2002
Primary Completion Date
May 31, 2006
radiation therapy
Undergo conventional radiation therapy
thalidomide
Given orally
quality-of-life assessment
Ancillary studies
Radiation Therapy Oncology Group, Philadelphia
Collaborators (1)
NRG Oncology
OTHER
National Cancer Institute (NCI)
NIH